These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15830328)

  • 1. Can we improve the management of blood donors with nonspecific reactivity in viral screening and confirmatory assays?
    Kiely P; Wood E
    Transfus Med Rev; 2005 Jan; 19(1):58-65. PubMed ID: 15830328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic screening for blood-borne viruses in transfusion settings.
    Lee HH; Allain JP
    Vox Sang; 1998; 74 Suppl 2():119-23. PubMed ID: 9704433
    [No Abstract]   [Full Text] [Related]  

  • 3. Results of HCV screening of volunteer blood donors with a chemiluminescent immunoassay and a second- or third-generation EIA: overlap of false-positive reactivity and its impact on donor management.
    Kiely P; Wilson D
    Transfusion; 2000 May; 40(5):580-4. PubMed ID: 10827263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview: diagnostic tests for viral infections transmitted by blood.
    Holland PV
    Nucl Med Biol; 1994 Apr; 21(3):407-17. PubMed ID: 9234305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of low cost peptide-based anti-hepatitis C virus screening and confirmatory assays: comparison with commercially available tests.
    Palacios A; Taylor L; Haue L; Luftig RB; Visoná KA
    J Med Virol; 1999 Jul; 58(3):221-6. PubMed ID: 10447416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dried sera for confirming blood-borne virus infections (HCV, HTLV-I, HIV & HBsAg).
    Das PC; de Vries AH; McShine RL; Sibinga CT
    Transfus Med; 1996 Dec; 6(4):319-23. PubMed ID: 8981726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of Liaison XL automated immunoassay platform for blood-borne infection screening on hepatitis B, hepatitis C, HIV 1/2, HTLV 1/2 and Treponema pallidum serological markers.
    Malm K; Kragsbjerg E; Andersson S
    Transfus Med; 2015 Apr; 25(2):101-5. PubMed ID: 25779614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term serologic follow-up of blood donors with biologic false reactivity on an anti-human T-cell lymphotropic virus Types I and II chemiluminescent immunoassay and implications for donor management.
    Kiely P; Thomas B; Kebede M
    Transfusion; 2008 Sep; 48(9):1833-41. PubMed ID: 18503614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of voluntary blood donors with biologic false reactivity on chemiluminescent immunoassays and implications for donor management.
    Kiely P; Stewart Y; Castro L
    Transfusion; 2003 May; 43(5):584-90. PubMed ID: 12702178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests.
    Hyland C; Seed CR; Kiely P; Parker S; Cowley N; Bolton W
    Vox Sang; 2003 Jul; 85(1):1-8. PubMed ID: 12823724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Residual risks of viral transmission by transfusions and projected yields of additional screening tests. Retrovirus Epidemiology Donors Study (REDS)].
    Busch MP
    Transfus Clin Biol; 1996; 3(1):7-11. PubMed ID: 8640316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood donors screening for blood born viruses in Poland.
    Grabarczyk P; Kopacz A; Sulkowska E; Kubicka-Russel D; Mikulska M; Brojer E; Łętowska M
    Przegl Epidemiol; 2015; 69(3):473-7, 591-5. PubMed ID: 26519842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening for viral genomes in blood transfusion].
    Coste J
    Transfus Clin Biol; 2000 Jun; 7 Suppl 1():11s-17s. PubMed ID: 10919218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Controlled viral risks].
    Barin F
    Transfus Clin Biol; 2000 Feb; 7(1):24-9. PubMed ID: 10730343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of third-generation HCV RIBA-indeterminate, RNA-negative results in voluntary blood donors screened with sequential third-generation immunoassays.
    Kiely P; Kay D; Parker S; Piscitelli L
    Transfusion; 2004 Mar; 44(3):349-58. PubMed ID: 14996191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing.
    Fang CT; Field SP; Busch MP; Heyns Adu P
    Vox Sang; 2003 Jul; 85(1):9-19. PubMed ID: 12823725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003.
    Coste J; Reesink HW; Engelfriet CP; Laperche S; Brown S; Busch MP; Cuijpers HT; Elgin R; Ekermo B; Epstein JS; Flesland O; Heier HE; Henn G; Hernandez JM; Hewlett IK; Hyland C; Keller AJ; Krusius T; Levicnik-Stezina S; Levy G; Lin CK; Margaritis AR; Muylle L; Niederhauser C; Pastila S; Pillonel J; Pineau J; van der Poel CL; Politis C; Roth WK; Sauleda S; Seed CR; Sondag-Thull D; Stramer SL; Strong M; Vamvakas EC; Velati C; Vesga MA; Zanetti A
    Vox Sang; 2005 May; 88(4):289-303. PubMed ID: 15877653
    [No Abstract]   [Full Text] [Related]  

  • 18. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.
    Owusu-Ofori S; Temple J; Sarkodie F; Anokwa M; Candotti D; Allain JP
    Transfusion; 2005 Feb; 45(2):133-40. PubMed ID: 15660820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of sample-to-cutoff ratios on chemiluminescent immunoassays used for blood donor screening highlights the need for serologic confirmatory testing.
    Kiely P; Walker K; Parker S; Cheng A
    Transfusion; 2010 Jun; 50(6):1344-51. PubMed ID: 20113456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of blood centers in the screening of blood donors for viral markers.
    Dogbe EE; Arthur F
    Pan Afr Med J; 2015; 20():119. PubMed ID: 26090067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.